January 2013 Webinar: “Practical Ways to Help Get Our Diabetes Patients to Goal” Controlling the ABC’s Cases.

Slides:



Advertisements
Similar presentations
1 Type 1 Diabetes Mellitus Treatment. 2 Goals of T1DM Management Utilize intensive therapy aimed at near-normal BG and A1C levels Prevent diabetic ketoacidosis.
Advertisements

The New HbA1c HbA1c – DCCT (%) HbA1c – IFFC (mmol/mol)
Monthly Diabetes Team Meeting First Things First.
Diabetes Mellitus in Clinical Practice Dr. Muhieddin Omar Dr. Raed Abu Sham’a.
Diabetes Mellitus.
1 Diabetes: The Burden of Disease Fall, 2007 NUR464.
Oral Medications to Treat Type 2 Diabetes
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Managing Diabetes Medications. Topics What medications are available to –Manage diabetes? –Lower blood pressure? –Improve cholesterol? How can you keep.
Canadian Diabetes Association 2013 Clinical Practice Guidelines Targets for Glycemic Control Chapter 8 S. Ali Imran, Rémi Rabasa-Lhoret, Stuart Ross.
Managing Diabetes What Is Diabetes? and Diabetes ABCs.
Barriers to Diabetes Control Mark E. Molitch, MD.
Insulin therapy.
What is Diabetes?.
Getting to Goal: ‘Practical Tricks of the trade‘ How to Achieve the ABCs Robert Gabbay MD, PhD Director Penn State Hershey Diabetes Institute Penn State.
LONG TERM BENEFITS OF ORAL AGENTS
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
TEST/CHECK A1C O Fasting blood glucose check O Post-prandial blood glucose check O (1-2 hours after a meal) Blood pressure OBlood pressure O LDL cholesterol.
Improving Medical Management of Diabetes
Rapid E clinical guidance in the management of Type 2 diabetes New Zealand Guidelines Group.
Criteria for Diagnosis of DM * Testing must be repeated on separate day. FPG is the preferred test ** Symptoms of DM IFG = Impaired fasting glucose IGT.
Diabetes Mellitus Ibrahim Sales, Pharm.D. Assistant Professor of Clinical Pharmacy King Saud University
IDC Diabetes Update: Recent Research and Impact on Diabetes Management Type 1 DiabetesType 1 Diabetes –Post DCCT findings--improving glycemic control and.
Epidemiology of Diabetes Mellitus by Santi Martini Departemen of Epidemiology Faculty of Public Health University of Airlangga.
Management of Inpatient Blood Glucose at Temple Housestaff Orientation 2014.
PRE-EXISTING DIABETES AND PREGNANCY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Criteria for the diagnosis of DM Symptoms of diabetes plus random blood glucose concentration ≥ 200 mg/dl OR FPG ≥ 126 mg/dl OR Two –hour plasma glucose.
What the GP Should Know about Diabetes Mellitus Dr. Muhieddin Omar.
Management of Type 2 Diabetes New Zealand Guidelines Group.
Claims-Based Quality Measures CMS Physician Group Practice Demonstration Project Chealsea Nather 26 January 2005.
Session II: Glycemic control, when the lower is not the better Strict glycemic control and cardiovascular diseases Stefano Genovese Diabetologia e Malattie.
Standards of Medical Care for Patients with Diabetes Mellitus John Guzek, MD March 2003.
Guidelines for Diabetes Management September 20, 2012 Margaret Pochay RD CDE.
Titrating Insulin to Glycemic Target Judy Bowen, MD CIM Rotation September, 2006.
Leveraging Weight Loss in the Treatment of Type 2 Diabetes Part 1 of 4.
NICE GUIDELINES HYPERTENSION Masroor Syed. Latest Issue June 2006 Evidence Based uickrefguide.pdf
Preferred treatment options for patients with Diabetes Dr Jon Tuppen GPwSI Beechwood Surgery Brentwood.
Improving Hypertension Quality Measurement Using Electronic Health Records S Persell, AN Kho, JA Thompson, DW Baker Feinberg School of Medicine Northwestern.
ORIGIN Outcome Reduction with an Initial Glargine Intervention (ORIGIN) Trial Overview Large international randomized controlled trial in patients with.
Cost-Effectiveness of Treatment Strategies for Comorbid Diabetes and Dyslipidemia Part 3.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015 Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor.
Basal Bolus: The Strategy for Managing All Diabetes Fall, 2003 Paul Davidson, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
DIABETES IN THE ELDERLY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
 GLP-1 agonists have shown to help patients lose weight  Mechanism of GLP-1 agonists  Cardioprotective effects of GLP-1 agonists  GLP-1 agonists and.
Diabetes Update Division of Endocrinology Department of Medicine Wayne State University Medical School Detroit, Michigan Part 1 of 3.
Therapy of Type 2 Diabetes Mellitus: UPDATE
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
Prevention Of Diabetes. Type 2 Diabetes: Hyperglycemia Insulin Resistance Relative Impairment of Insulin Secretion Pathogenesis: Poorly Understood Genetic.
 Provide a high level overview of diabetes head to toe.  Discuss the importance of keeping A1Cs under 8.  Identify ways to prevent long-term complications.
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA.
February 2013 Webinar: “Practical Ways to Help Get Our Diabetes Patients to Goal” Controlling the ABC’s Cases.
Oral Diabetes Medications Carol Cordy, MD. Goals Understand how type 2 diabetes affects many organs and how this changes over the course of the illness.
Therapy for Type II Diabetes. Non-Insulin Therapy for Hyperglycemia in Type 2 Diabetes, Match Patient Characteristics to Drug Characteristics 5. Gut.
Diabetes. Objectives: Diabetes Mellitus (DM) Discuss the prevalence of diabetes in the U.S. Contrast the main types of diabetes. Describe the classic.
Improving Adherence in Type 2 Diabetes Mellitus ALLISON PETZNICK DO NOMS FAMILY MEDICINE SANDUSKY, OH.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
Utilizing Anti-diabetic Agents to Manage Cardiovascular Disease in T2DM Patients James LaSalle, D.O., FAAFP.
Glycemia Treatment Strategies Used In ACCORD
CHANGES in ada 2015.
Copyright © 2015 by the American Osteopathic Association.
Objective 2 Discuss recent data, guidelines, and counseling points pertaining to the older adults with diabetes.
ACCORD Design and Baseline Characteristics
Vanguard Phase Results for the Blood Pressure Component
Heart Health & Diabetes
Macrovascular Complications Microvascular Complications
Diabetes Dr. J. Antony Gagnon, Pharm.D., CDE, CAE
Integrated Diabetes Care: How Can We Make the Best Use of New Technology?
RCHC’s Cardiovascular Health Initiative
Strategies for the Practical Management of Type 2 Diabetes
Insulin Delivery Systems Atlanta Diabetes Associates
Presentation transcript:

January 2013 Webinar: “Practical Ways to Help Get Our Diabetes Patients to Goal” Controlling the ABC’s Cases

Evidence Based Interventions that Reduce Morbidity and Mortality HbA1C < 7 BP < 140/90 LDL cholesterol < 100 (or <70 if CAD) Aspirin age > 50 men, 60 women with 1 risk factor ACE - age >55 Statin use - age >40 Yearly screen for nephropathy, feet, and eye exams

The ‘ABCs’ A 1C B P < 140/90 C holesterol (LDL<100, if CAD <70)

Improving Glucose Control

“But I Thought It Was Bad to Lower A1C Too Much..” All recent studies aimed at A1C = 6.5 or lower No evidence that A1C = 7 is bad Data says to reduce CVD It is not so much about glucose It’s the Blood Pressure and Cholesterol!

Really, Really Important Points: 1.Aggressive control early prevents complications 2.Because of the log-linear relationship between control and complications, absolute benefits are greatest at high HbA1c values (i.e. target A1C >9) 3.Pushing patients with advanced disease (particularly macrovascular complications) to ‘tight’ control that they cannot achieve probably increases mortality -Attention to hypoglycemia and particularly nocturnal hypoglycemia

Managing Glucose Goal A1C <7 Consider higher (8) if CAD, elderly, or hypoglycemia unawareness Focus on those at highest risk (i.e. A1C >9)

Sites of Drug ActionCarbohydrate DIGESTIVE ENZYMES Glucose Defective -cell secretion  -cell secretion Excessglucoseproduction Resistance to the action of insulin Reduced glucose uptake Excessivelipolysis Dinneen SF. Diabet Med. 1997; 14 (Suppl 3): S Sulfonlyureas Meglitinides Incretins Insulin Alpha-glucosidase Inhibitors, Incretins Metformin TZD Incretins TZD, Metformin

Points to Remember Each agent, except insulin, lowers A1C 1-2 If A1C >9, start two agents Follow SMBG, A1C, and Titrate!!!!!

Case 58 yo with Type 2 x 5 yrs A1C = 9.5 On metformin 1000 mg bid Glimepiride 4 mg qd What next?

 20  Natural History of Type 2 Diabetes Adapted from International Diabetes Center (IDC). Minneapolis, Minnesota. Years of Diabetes Relative  -Cell Function Plasma Glucose Insulin resistance Insulin secretion 126 mg/dL Fasting glucose Postmeal glucose

Type 2 Diabetes… A Progressive Disease Over time, most patients will need insulin to control glucose.

Reducing Clinical Inertia Eternal hope on lifestyle working Negotiate a deadline Escalating therapy more quickly Oral agents can be monthly Insulin can be weekly

Barriers to Starting Insulin Patient Barriers Guilt, failure Injection? Provider Barriers Who teaches? Consider pens Team Based Care to the rescue! Diabetes Educators?

Talking About Insulin “It seems like you have some concerns about insulin?” “What do you know about using insulin in DM?” Inevitable Simple Pens Can be daily at first No one needs to know Correct misconceptions

What To Do With Oral Agents Negotiate For weight- keep metformin For reducing need for second injection - insulin secretagouge For cost- stop orals

Correcting Fasting Hyperglycemia… Normal A1C 5%–6% PG (mg/dL) Time of Day Uncontrolled A1C ~9% A1C ~6% Is Usually the First Task!! …then, Tackle Postprandial Hyperglycemia if A1C still >7%! “Controlled” A1C <7%

Titrating Glargine or Detemir Start 10 units 2 units q 3 days until FPG < 100 It’s that easy and it works!

50 4: :0012:0016:0020:0024:004:00 BreakfastLunchDinner Plasma Insulin ( U/mL) Insulin ( µU/mL) Time 8:00 Physiologic Serum Insulin Secretion Profile

How do you know they need another injection? FPG good but A1C not

22

Case Type 2 DM x 6 y Glargine 60 units qhs FPG A1C=8.5 Pt can measure qhs BG? Start 10 units rapid insulin pre-dinner If regular meals- 70/30 insulin 40 q Am, 30 q PM

Who Are Your High A1C Patients? Orals and need second oral? Need insulin? On insulin? There can be inertia at each level DEPRESSION? Adherence? Open-ended ended question: “Some people find it hard taking their insulin every day, how’s it going for you?”

BP CONTROL

BP Management <140/90 Multiple meds Don’t miss an opportunity to titrate Standing orders?

Medication Treatment Algorithm? Start with ACE or ARB and/or HCTZ Either one Best might be early combo since all will likely need it Third agent based on co-morbidity Beta blocker and/or Ca channel Add the 4 th and hopefully you’ve reached goal - if not call an expert +/- alpha blocker?

Tashko and Gabbay, Integrated Blood Pressure Control (2010)

Cholesterol LDL control <100 If CVD <70

Getting to Goal on LDL Most myalgia not from statins! Stop and observe Switch to another statin Mention stroke risk TITRATE

Evidence Based Interventions That Reduce Morbidity and Mortality HbA1C < 7 BP < 130/80 LDL cholesterol < 100 (or <70 if CAD) Aspirin age > 50 men, 60 women with 1 risk factor ACE -age >55 Statin use- age >40 Yearly screen for nephropathy, feet, and eye exams

QUESTIONS? Any Cases?